The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends

Emerging Role of Postmarketing Clinical Research is a report published by Business Insights that uses detailed case studies and market scenarios to examine the latest issues surrounding phase IV trial applications. The potential to leverage competitive advantage with postmarketing research is assessed by measuring the implications for formulary access, product marketing, indication expansion and reimbursement coverage.

This report also explores the regulatory issues and requirements affecting mandatory postmarketing trial conduct and identifies the key components of effective phase IV trial design and completion. Identify the latest regulatory developments affecting postmarketing clinical research, use case studies to evaluate recent phase IV trial implementations and understand the competitive potential of successful trial designs.

Read more...

• eCTD for Regulatory Affairs and beyond.. (18/12/2008)
• Rx-to-OTC Strategies (10/10/2008)
• Biosimilars-Regulatory Issues (27/05/2008)

• Acute Stroke (10/06/2008)
• Online Patient Recruitment (10/06/2008)
• Pricing & Reimbursement (10/06/2008)

• Contract Manufacturing Strategies (10/06/2008)
• Restricted Drug Distribution (02/06/2008)
• Chinese Pharmaceutical Market Overview (27/05/2008)
• Antithrombotics (27/05/2008)
• Migraine (27/05/2008)
• Gynecological Cancers (27/05/2008)
• Pricing and Reimbursement in Oncology (27/05/2008)
• Obesity (27/05/2008)
• Therapeutic Cancer Vaccines (27/05/2008)

---